Complicated Urinary Tract Infection Clinical Trials
3 recruiting trials for Complicated Urinary Tract Infection. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT06672978
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With...
The primary objective of the study is to assess the safety and tolerability of meropenem-vaborbactam administered by intravenous (IV) infusion in children 3 months and above to...
Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)Enrolling: 6620 locations
RECRUITINGPhase 4NCT04876131
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
Urinary tract infections (UTI) are commonly encountered in children, with 7% diagnosed with at least one UTI by the age of 19 years. The evidence for treatment of uncomplicated...
Sponsor: Murdoch Childrens Research InstituteEnrolling: 4526 locations
RECRUITINGNCT05733104
A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
The purpose of this study is to learn about the safety and effectiveness of Zavicefta once released into the markets in Korea. This study is to learn about Zavicefta in patients...
Sponsor: PfizerEnrolling: 6001 location